Cargando…
Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens
Infectious bronchitis (IB) is a highly contagious upper respiratory tract disease of chickens caused by infectious bronchitis virus (IBV), which has various serotypes that do not cross-protect. Vaccine control strategies for this virus are only effective when designed around the currently circulatin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113781/ https://www.ncbi.nlm.nih.gov/pubmed/31712094 http://dx.doi.org/10.1016/j.jviromet.2019.113773 |
_version_ | 1783513746125094912 |
---|---|
author | Mo, Jongseo Angelichio, Michael Gow, Lisa Leathers, Valerie Jackwood, Mark W. |
author_facet | Mo, Jongseo Angelichio, Michael Gow, Lisa Leathers, Valerie Jackwood, Mark W. |
author_sort | Mo, Jongseo |
collection | PubMed |
description | Infectious bronchitis (IB) is a highly contagious upper respiratory tract disease of chickens caused by infectious bronchitis virus (IBV), which has various serotypes that do not cross-protect. Vaccine control strategies for this virus are only effective when designed around the currently circulating serotypes. It is essential to not only rapidly detect IBV but also to identify the type of virus causing disease. Six TaqMan™-based quantitative real-time RT-PCR assays (Universal, Ark, Mass, DE/GA98, GA07, GA08) were developed and examined the sensitivity and specificity for each assay. Assays were developed targeting the hypervariable region in the S1 gene subunit. The analytical sensitivity of TaqMan™-based quantitative real-time RT-PCR assays (qRT-PCR) assays was evaluated using synthetic DNA standards that were identical with the target sequence and specificity was further validated using clinical and biological specimens. All developed assays performed equivalently when using synthetic DNA templates as standard material, as it achieved linearity over a 5 log(10) dynamic range with a reproducible limit of detection of ≤10 target copies per reaction, with high calculated amplification efficiencies ranging between 90%–115%. Further validation of specificity using clinical and biological specimens was also successful. |
format | Online Article Text |
id | pubmed-7113781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Authors. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71137812020-04-02 Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens Mo, Jongseo Angelichio, Michael Gow, Lisa Leathers, Valerie Jackwood, Mark W. J Virol Methods Article Infectious bronchitis (IB) is a highly contagious upper respiratory tract disease of chickens caused by infectious bronchitis virus (IBV), which has various serotypes that do not cross-protect. Vaccine control strategies for this virus are only effective when designed around the currently circulating serotypes. It is essential to not only rapidly detect IBV but also to identify the type of virus causing disease. Six TaqMan™-based quantitative real-time RT-PCR assays (Universal, Ark, Mass, DE/GA98, GA07, GA08) were developed and examined the sensitivity and specificity for each assay. Assays were developed targeting the hypervariable region in the S1 gene subunit. The analytical sensitivity of TaqMan™-based quantitative real-time RT-PCR assays (qRT-PCR) assays was evaluated using synthetic DNA standards that were identical with the target sequence and specificity was further validated using clinical and biological specimens. All developed assays performed equivalently when using synthetic DNA templates as standard material, as it achieved linearity over a 5 log(10) dynamic range with a reproducible limit of detection of ≤10 target copies per reaction, with high calculated amplification efficiencies ranging between 90%–115%. Further validation of specificity using clinical and biological specimens was also successful. The Authors. Published by Elsevier B.V. 2020-02 2019-11-08 /pmc/articles/PMC7113781/ /pubmed/31712094 http://dx.doi.org/10.1016/j.jviromet.2019.113773 Text en © 2019 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mo, Jongseo Angelichio, Michael Gow, Lisa Leathers, Valerie Jackwood, Mark W. Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens |
title | Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens |
title_full | Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens |
title_fullStr | Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens |
title_full_unstemmed | Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens |
title_short | Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens |
title_sort | validation of specific quantitative real-time rt-pcr assay panel for infectious bronchitis using synthetic dna standards and clinical specimens |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113781/ https://www.ncbi.nlm.nih.gov/pubmed/31712094 http://dx.doi.org/10.1016/j.jviromet.2019.113773 |
work_keys_str_mv | AT mojongseo validationofspecificquantitativerealtimertpcrassaypanelforinfectiousbronchitisusingsyntheticdnastandardsandclinicalspecimens AT angelichiomichael validationofspecificquantitativerealtimertpcrassaypanelforinfectiousbronchitisusingsyntheticdnastandardsandclinicalspecimens AT gowlisa validationofspecificquantitativerealtimertpcrassaypanelforinfectiousbronchitisusingsyntheticdnastandardsandclinicalspecimens AT leathersvalerie validationofspecificquantitativerealtimertpcrassaypanelforinfectiousbronchitisusingsyntheticdnastandardsandclinicalspecimens AT jackwoodmarkw validationofspecificquantitativerealtimertpcrassaypanelforinfectiousbronchitisusingsyntheticdnastandardsandclinicalspecimens |